Patent · US Expired

Use of carbazole compounds for the treatment of congestive heart failure

US5902821A · kind A · utility

23Cited by

3References

11Claims

0Family size

Assignee

Boehringer Mannheim Pharmaceuticals Corporation Smith Kline Corporation Limited Partnership No. 1 · US

Inventors

Mary Ann Lukas-Laskey · Rosemont, US
Robert Ruffolo · Spring City, US
Neil Howard Shusterman · Lansdowne, US
Gisbert Sponer · Hemsbach, DE
Klaus Strein · Hemsbach, DE

Key dates

Filing date	Dec 29, 1997
Grant date	May 11, 1999
Priority date	—
Expiry date	Dec 29, 2017

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treatment using carvedilol is disclosed, wherein the carvedilol decreases the mortality caused by congestive heart failure in patients. The patients are titrated with low amounts of carvedilol, with the initial titration dosage being only 10 to 30% of the daily maintenance dose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.